Stay updated on GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page revision/version indicator was updated from v3.5.2 to v3.5.3 for the ClinicalTrials.gov record history interface.
    Difference
    0.1%
    Check dated 2026-04-25T06:03:18.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0 from the history page.
    Difference
    0.1%
    Check dated 2026-04-18T03:50:21.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    47 days ago
    Change Detected
    Summary
    The page history now includes a new revision labeled v3.5.0 and removes the previous v3.4.3 entry.
    Difference
    0.1%
    Check dated 2026-03-20T04:55:31.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Added revision v3.4.3 to the record history and removed revision v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-05T19:28:25.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    A new revision entry v3.4.2 was added and the previous revision v3.4.1 was removed in the page history. This is a metadata update to the history log and does not affect study data or page functionality.
    Difference
    0.1%
    Check dated 2026-02-12T03:56:49.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Revision metadata updated: 'Revision: v3.4.1' was added and 'Revision: v3.4.0' was removed. This change affects only page revision information and does not modify study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T01:41:01.000Z thumbnail image

Stay in the know with updates to GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial page.